Advertisement
YOU ARE HERE: LAT HomeCollections

Earnings

SPI Pharmaceuticals Inc., which is owned primarily by ICN...

June 27, 1989

SPI Pharmaceuticals Inc., which is owned primarily by ICN Pharmaceuticals Inc., posted record net income of $3.8 million for its second quarter ended May 31. That represents a 27% increase from the $3 million reported for the same period last year. Sales in the quarter rose 10% to $30.3 million from $27.5 million. For the first half, net income totaled $6.4 million, 47% higher than the $4.4 million posted a year earlier. Sales increased 17% to $59.9 million from $51.1 million. The Costa Mesa-based pharmaceutical products manufacturer said sales growth in its international operations, particularly in Mexico, contributed to the second-quarter gains.

Advertisement
Los Angeles Times Articles
|
|
|